Gopal-Srivastava R, Piatigorsky J
Laboratory of Molecular and Developmental Biology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892.
Nucleic Acids Res. 1994 Apr 11;22(7):1281-6. doi: 10.1093/nar/22.7.1281.
Previous studies have shown that the -661/+44 sequence of the murine alpha B-crystallin gene contains a muscle-preferred enhancer (-426/-257) and can drive the bacterial chloramphenicol acetyltransferase (CAT) gene in the lens, skeletal muscle and heart of transgenic mice. Here we show that transgenic mice carrying a truncated -164/+44 fragment of the alpha B-crystallin gene fused to the CAT gene expressed exclusively in the lens; by contrast mice carrying a -426/+44 fragment of the alpha B gene fused to CAT expressed highly in the lens, skeletal muscle and heart, and slightly in the lung, brain, kidney, spleen and liver. DNase I protection experiments indicated that the -147/-118 sequence is protected by nuclear proteins from alpha TN4-1 lens cell line, but not by nuclear proteins from myotubes of the C2C12 cell line. Site directed mutagenesis of this sequence decreased promoter activity in transiently-transfected lens cells, consistent with this sequence being a lens-specific regulatory region (LSR). We conclude that the -426/-257 enhancer is required for expression in skeletal muscle, heart and possibly other tissues, and that the -164/+44 sequence of the alpha B-crystallin gene is sufficient for expression in the lens of transgenic mice.
先前的研究表明,小鼠αB-晶状体蛋白基因的-661/+44序列包含一个肌肉优先增强子(-426/-257),并且可以在转基因小鼠的晶状体、骨骼肌和心脏中驱动细菌氯霉素乙酰转移酶(CAT)基因的表达。在此我们表明,携带与CAT基因融合的αB-晶状体蛋白基因截短的-164/+44片段的转基因小鼠仅在晶状体中表达;相比之下,携带与CAT基因融合的αB基因的-426/+44片段的小鼠在晶状体、骨骼肌和心脏中高表达,在肺、脑、肾、脾和肝脏中低表达。DNase I保护实验表明,-147/-118序列受到αTN4-1晶状体细胞系的核蛋白保护,但未受到C2C12细胞系肌管的核蛋白保护。该序列的定点诱变降低了瞬时转染的晶状体细胞中的启动子活性,这与该序列是晶状体特异性调节区域(LSR)一致。我们得出结论,-426/-257增强子是在骨骼肌、心脏及可能的其他组织中表达所必需的,并且αB-晶状体蛋白基因的-164/+44序列足以在转基因小鼠的晶状体中表达。